Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1994-07-07
1995-11-14
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
562565, 436173, 534 16, 514492, 514502, 514836, 556 50, 556 55, 556 63, 556 77, 556105, 556116, 556134, 556148, A61B 5055
Patent
active
054664390
ABSTRACT:
A polymeric contrast enhancing agent for magnetic resonance images having a chelating agent, which can be bound to metal ions having at least one unpaired electron, such as gadolinium. Examples of such chelating agents include DTPA-ethylenediamide-methacrylate copolymer and poly-(DTPA-ethylenediamide). These contrast enhancing agents, bound to the metal ions, are then administered to a patient, and following this the MR images are taken.
REFERENCES:
patent: 4880008 (1989-11-01), Lauffer
patent: 5011925 (1991-04-01), Rajagopalan
patent: 5023072 (1991-06-01), Cheng
patent: 5057302 (1991-10-01), Johnson et al.
patent: 5138040 (1992-08-01), Moore et al.
patent: 5155215 (1992-10-01), Ranney
patent: 5290537 (1994-03-01), Moore et al.
patent: 5312617 (1994-05-01), Unger et al.
patent: 5403576 (1995-04-01), Lin et al.
Gibby Wendell A.
Puttagunta N. Rao
Drucker I. Morley
Hollinden Gary E.
Kimbell Daniel R.
Magnetic Research, Inc.
Sommers Howard N.
LandOfFree
Polymeric contrast enhancing agents for magnetic resonance image does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymeric contrast enhancing agents for magnetic resonance image, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymeric contrast enhancing agents for magnetic resonance image will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1219141